Phase Transitioning Polymers for Localized Therapies

26 concepts20 papers

When delivering medicine to a specific site in the body, clinicians face a fundamental physical dilemma. If they inject a liquid, it easily flows through a fine needle and conforms to the irregular geometry of the target tissue, but it quickly leaks away into the bloodstream or surrounding areas. If they use a solid implant, it stays exactly where it is needed, but placing it requires invasive surgery, and it cannot adapt to dynamic, irregular anatomical spaces.

To bridge this gap, researchers have developed in situ gelation—a strategy where a material is administered as a low-viscosity liquid but rapidly transforms into a solid or highly viscous gel once inside the body. This approach combines the delivery ease of a liquid with the structural stability of a solid.

The Thermodynamic Switch: How Temperature Drives Gelation

The most common way to trigger this transformation is by exploiting the temperature differential between the outside environment (room temperature, ~20°C) and the inside of the body (physiological temperature, ~37°C).

To understand why a polymer solution would solidify when heated—defying our everyday intuition that heat melts things—we have to look at the balance between hydrophilic and hydrophobic molecular interactions. Many thermosensitive hydrogels rely on amphiphilic block copolymers, such as poloxamers or PLGA-PEG-PLGA triblocks, which contain both water-loving (hydrophilic) and water-hating (hydrophobic) segments.

Room Temperature (~20°C)                  Body Temperature (~37°C)
   [Free Polymer Chains]                     [Micellar Jamming]
  ~~~~~~~~~  ~~~~~~~~~  ~~~~~~~~~               O   O   O   O   O
  ~~~~~~~~~  ~~~~~~~~~  ~~~~~~~~~             O   O   O   O   O   O
  (Low viscosity, flows easily)               O   O   O   O   O   O
                                         (Rigid, jammed 3D gel network)

At room temperature, hydrogen bonding between water molecules and the hydrophilic parts of the polymer dominates. The water molecules form highly ordered "cages" around the hydrophobic segments. Because the polymer chains remain individual and well-solvated, the solution behaves as a low-viscosity liquid that can be easily mixed with therapeutics, sprayed, or injected.

When the mixture enters the body, the sudden rise in temperature injects thermal energy into the system, disrupting these weak hydrogen bonds. Thermodynamically, the system seeks to maximize entropy. It does this by freeing the structured water molecules from their cages. To minimize contact with water, the hydrophobic segments of the polymer collapse toward one another, causing the chains to self-assemble into spherical structures called micelles.

As the temperature approaches 37°C, the concentration of these micelles becomes so high that they crowd and lock against one another—a phenomenon known as micellar jamming. This transition from free-flowing chains to a packed micellar network instantly turns the liquid into a rigid 3D gel matrix.

Gao et al. demonstrated this mechanism using a synthesized PLGA-PEG-PLGA triblock copolymer to encapsulate a DNA vaccine, showing that easy mixing at room temperature followed by rapid in situ gelation upon injection creates an ideal sustained-release platform. Similarly, Delgado et al. utilized poloxamer-based hydrogels to ensure that localized liver therapies rapidly solidify at physiological temperatures, preventing the therapeutic payload from washing out into the systemic circulation.

Alternative Triggers: Solvent Diffusion and Electrostatics

Temperature is not the only physical trigger available to material scientists. In situ gelation can also be achieved through chemical shifts or solvent exchange when the formulation meets physiological fluids.

Solvent Diffusion

Instead of relying on temperature-induced structural changes, some systems use a water-miscible organic solvent (like ethanol) to keep a water-insoluble polymer dissolved. As explored by Li et al., when a phospholipid-based formulation dissolved in ethanol is injected into tissue, the ethanol rapidly diffuses out into the surrounding aqueous interstitial fluid. Deprived of its organic solvent, the lipid components instantly precipitate, transforming the low-viscosity injectate into a highly viscous, localized gel depot.

A similar principle of viscosity modification was leveraged by Yang et al., who added ethyl cellulose to ethanol injections for liver ablation. The polymer additive transforms a highly volatile liquid into a localized gel-like state, preventing the destructive chemical from leaking into healthy tissue.

Electrostatic and Enzymatic Cross-linking

Other systems exploit the sudden change in ionic environment or molecular structure upon injection. For example, Wang et al. developed a chitosan-based hydrogel that undergoes rapid solidification at body temperature driven by electrostatic interactions between the polymer chains and local ions.

In tissue engineering, Zhang et al. demonstrated that an extracellular matrix powder can be enzymatically digested into a liquid pre-gel at cool temperatures. Once injected, the physiological temperature triggers the natural self-assembly of collagenous proteins, cross-linking the liquid into a stable, biomimetic 3D scaffold that perfectly matches the geometry of the cavity.

Why It Works: Solving the Leakage and Clearance Problem

The core value of in situ gelation lies in its ability to overcome the primary failure modes of local drug delivery: rapid clearance and systemic toxicity.

When a standard liquid drug is applied to a highly vascularized or dynamic environment, the body's natural clearance mechanisms—such as blood flow, lymphatic drainage, or ciliary clearance—quickly sweep the molecules away. This requires higher, more frequent doses, which increases the risk of systemic side effects.

An in situ forming gel acts as a physical anchor. By solidifying within seconds of contact, the gel creates a localized reservoir, or "depot," that physically traps the therapeutic payload. The drug can then only escape via slow, controlled diffusion through the polymer mesh or as the polymer matrix itself gradually degrades.

Traditional Liquid Injection                 In Situ Hydrogel Depot
      [ Rapid Washout ]                         [ Sustained Release ]

     │  │  │  │  │  │                          │  │  │  │  │  │
  ───┴──┴──┴──┴──┴──┴───                    ───┴──┴──┴──┴──┴──┴───
    →  →  Drug  →  →                          →  [▓▓▓▓▓▓▓▓▓]  →
    →  →  Flow  →  →                          →  [  Gel   ]  →
  ───┬──┬──┬──┬──┬──┬───                    ───┬──┬──┬──┬──┬──┬───
     │  │  │  │  │  │                          │  │  │  │  │  │
  (Drug enters bloodstream;                  (Gel anchors payload;
   short local lifetime)                      slow, localized diffusion)

This spatial containment has been successfully applied across several distinct medical challenges:

  • Vascular Restenosis: After blood vessel surgery, arteries frequently narrow again due to cellular overgrowth. Early pioneering work by Simons et al. showed that applying a thermosensitive hydrogel to the outside of an injured artery creates a stable extraluminal reservoir for sustained oligonucleotide delivery. Decades later, Shi et al. utilized a similar "outside-in" approach, using a thermosensitive gel to anchor rapamycin-loaded nanoparticles directly to the surgical site, preventing systemic wash-out and achieving sustained inhibition of vascular narrowing.
  • Locoregional Cancer Therapy: Injecting chemotherapy directly into tumors minimizes systemic damage, but traditional liquids leak into surrounding healthy tissues. Delgado et al. and Delgado et al. demonstrated in swine models that imageable thermosensitive hydrogels remain strictly localized after percutaneous injection, significantly reducing the amount of toxic drug escaping into the systemic circulation compared to a free drug injection.
  • Dynamic Mucosal Barriers: Hu et al. adapted this concept into a sprayable "intranasal mask." The formulation is applied as a fine liquid mist that instantly transitions into a porous gel upon contact with the warm nasal mucosa. This creates a stable, shape-adaptive physical barrier capable of intercepting and neutralizing viral aerosols directly in the respiratory tract.

By turning the body's own physiological parameters—temperature, ions, and fluid environments—into a chemical switch, in situ gelation transforms simple polymer solutions into smart, highly adaptive delivery systems. The reader can see that the success of this approach relies not on complex mechanical devices, but on elegant thermodynamic design: exploiting molecular self-assembly to build a solid defense exactly where it is needed most.

History & citationVersion 1 · 2026-10-04

Current · Permanent link

View frozen version 1

Cite this direction

Latest version (a living page):

@misc{lacuna_in_situ_gelation_74cb2d4e,
  title = {in situ gelation},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/in-situ-gelation/rdr_74cb2d4e3a554beeb8c65ace05ca06cf},
  note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}

This exact version (version 1, frozen text):

@misc{lacuna_in_situ_gelation_74cb2d4e_v1,
  title = {in situ gelation},
  author = {{Lacuna}},
  howpublished = {Lacuna research direction},
  year = {2026},
  url = {https://lacuna.tiptreesystems.com/direction/in-situ-gelation/rdr_74cb2d4e3a554beeb8c65ace05ca06cf/v/1},
  note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}

See something wrong? Report a mistake